Los Angeles Court Rejects Patrick Soon-Shiong?s Attempt to Avoid Sorrento Litigation Allowing Arbitration Case to Move Forward

SAN DIEGO, Oct. 15, 2019 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”) announced today that a Los Angeles Superior Court judge has rejected Patrick Soon-Shiong?s attempt to allow him and his company, NantPharma, to avoid the billion-dollar fraud and breach of contract claims that Sorrento filed against them earlier this year.? Sorrento?s claims relate to the ?catch and kill? scheme that Soon-Shiong allegedly orchestrated to keep Sorrento?s promising cancer drug, Cynviloq, off the market in order to preserve Soon-Shiong?s personal financial interest in another competing drug.